Ioannis Ntanasis‐Stathopoulos
About
Ioannis Ntanasis‐Stathopoulos is a scholar working on Hematology, Oncology and Molecular Biology.
According to data from OpenAlex, Ioannis Ntanasis‐Stathopoulos has authored 268 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Hematology, 111 papers in Oncology and 90 papers in Molecular Biology. Recurrent topics in Ioannis Ntanasis‐Stathopoulos's work include Multiple Myeloma Research and Treatments (135 papers), Peptidase Inhibition and Analysis (39 papers) and Protein Degradation and Inhibitors (39 papers). Ioannis Ntanasis‐Stathopoulos is often cited by papers focused on Multiple Myeloma Research and Treatments (135 papers), Peptidase Inhibition and Analysis (39 papers) and Protein Degradation and Inhibitors (39 papers). Ioannis Ntanasis‐Stathopoulos collaborates with scholars based in Greece, United States and United Kingdom. Ioannis Ntanasis‐Stathopoulos's co-authors include Evangelos Terpos, Meletios Α. Dimopoulos, Maria Gavriatopoulou, Efstathios Kastritis, Θεοδώρα Ψαλτοπούλου, Theodoros Ν. Sergentanis, Despina Fotiou, Marianna Politou, Diamantis I. Tsilimigras and Ismaı̈l Elalamy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
In The Last Decade
Ioannis Ntanasis‐Stathopoulos
243 papers receiving 5.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ioannis Ntanasis‐Stathopoulos Greece | 35 | 2.0k | 1.9k | 1.4k | 1.3k | 941 | 268 | 5.9k | ||
| Maria Gavriatopoulou Greece | 37 | 2.0k 1.0× | 1.0k 0.5× | 2.5k 1.7× | 2.2k 1.7× | 540 0.6× | 376 | 5.5k | ||
| Riccardo Haupt Italy | 40 | 1.2k 0.6× | 716 0.4× | 466 0.3× | 970 0.7× | 1.1k 1.1× | 191 | 5.2k | ||
| Michael von Bergwelt‐Baildon Germany | 41 | 3.4k 1.7× | 808 0.4× | 614 0.4× | 1.1k 0.8× | 490 0.5× | 214 | 6.3k | ||
| Jeffrey I. Zwicker United States | 34 | 805 0.4× | 518 0.3× | 1.1k 0.8× | 743 0.6× | 396 0.4× | 134 | 5.5k | ||
| Roberto Caporali Italy | 56 | 743 0.4× | 802 0.4× | 1.7k 1.2× | 1.1k 0.8× | 573 0.6× | 450 | 10.4k | ||
| Eun Bong Lee South Korea | 39 | 1.1k 0.5× | 507 0.3× | 1.7k 1.2× | 980 0.7× | 299 0.3× | 242 | 7.2k | ||
| Wen Zhang China | 37 | 556 0.3× | 805 0.4× | 372 0.3× | 834 0.6× | 563 0.6× | 245 | 5.4k | ||
| Sameer Bakhshi India | 34 | 1.4k 0.7× | 227 0.1× | 685 0.5× | 911 0.7× | 439 0.5× | 509 | 5.2k | ||
| Lai‐Shan Tam Hong Kong | 55 | 922 0.5× | 465 0.2× | 1.0k 0.7× | 1.5k 1.1× | 446 0.5× | 290 | 10.2k | ||
| Efstathios Kastritis Greece | 58 | 5.7k 2.8× | 2.2k 1.1× | 5.5k 3.8× | 6.8k 5.1× | 1.2k 1.2× | 583 | 15.0k |
Countries citing papers authored by Ioannis Ntanasis‐Stathopoulos
Since
Specialization
Citations
This map shows the geographic impact of Ioannis Ntanasis‐Stathopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioannis Ntanasis‐Stathopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioannis Ntanasis‐Stathopoulos more than expected).
Fields of papers citing papers by Ioannis Ntanasis‐Stathopoulos
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ioannis Ntanasis‐Stathopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioannis Ntanasis‐Stathopoulos. The network helps show where Ioannis Ntanasis‐Stathopoulos may publish in the future.
Co-authorship network of co-authors of Ioannis Ntanasis‐Stathopoulos
This figure shows the co-authorship network connecting the top 25 collaborators of Ioannis Ntanasis‐Stathopoulos. A scholar is included among the top collaborators of Ioannis Ntanasis‐Stathopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioannis Ntanasis‐Stathopoulos. Ioannis Ntanasis‐Stathopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Eleutherakis‐Papaiakovou, Evangelos, Nikolaos Kanellias, Ioannis Ntanasis‐Stathopoulos, et al.. (2025). The Role of the Bone Marrow Microenvironment in Physical Function and Quality of Life in Patients with Multiple Myeloma After First-Line Treatment with Novel Agents and Autologous Transplantation. SHILAP Revista de lepidopterología. 5(2). 21–21.
2.
Eleutherakis‐Papaiakovou, Evangelos, Magdalini Migkou, Nikolaos Kanellias, et al.. (2025). Effects of Exercise Training on the Bone Marrow Immune Microenvironment and Minimal Residual Disease in Multiple Myeloma Patients Following First‐Line Treatment. Scandinavian Journal of Medicine and Science in Sports. 35(2). e70020–e70020.
3.
Gavriatopoulou, Maria, Ioannis Ntanasis‐Stathopoulos, Emmanouil Spanoudakis, et al.. (2025). Second Primary Malignancies and Disease Transformation in Patients With Symptomatic Waldenström’s Macroglobulinemia. Clinical Lymphoma Myeloma & Leukemia. 25(10). e818–e825.e2.
4.
Terpos, Evangelos, Panagiotis Malandrakis, Ioannis Ntanasis‐Stathopoulos, et al.. (2025). Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post-ASCT in myeloma. Blood. 145(20). 2353–2360.
5.
Malandrakis, Panagiotis, et al.. (2025). Current Treatment Strategies for Multiple Myeloma at First Relapse. Journal of Clinical Medicine. 14(5). 1655–1655.
6.
Tsilimigras, Diamantis I., et al.. (2025). Liquid Biopsies in the Early Diagnosis, Prognosis, and Tailored Treatment of Colorectal Cancer. Cancers. 17(6). 927–927.
7.
Efentakis, Panagiotis, Grzegorz Kwiatkowski, Aimilia Varela, et al.. (2024). Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin. Basic Research in Cardiology. 120(1). 263–286.
8.
Ntanasis‐Stathopoulos, Ioannis, Evdoxia Hatjiharissi, Emmanouil Spanoudakis, et al.. (2024). Real-World Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with Teclistamab and Talquetamab; A Multicenter Analysis from the Greek Myeloma Study Group. Blood. 144(Supplement 1). 6988–6988.
9.
Terpos, Evangelos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, et al.. (2024). Evaluation of a novel method to guide belantamab mafodotin dosing in multiple myeloma based on a patient-reported questionnaire.. Journal of Clinical Oncology. 42(16_suppl). 7530–7530.
10.
Kostopoulos, Ioannis V., Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, et al.. (2024). Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma. American Journal of Hematology. 99(10). 1887–1896.
11.
Ntanasis‐Stathopoulos, Ioannis, et al.. (2023). Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis. Cancers. 15(8). 2266–2266.
12.
Malandrakis, Panagiotis, Ioannis Ntanasis‐Stathopoulos, Ioannis V. Kostopoulos, et al.. (2023). P861: PERSISTENT BONE MARROW AND IMAGING MRD NEGATIVITY AS CRITERIA TO STOP LENALIDOMIDE MAINTENANCE FOLLOWING ASCT: PRELIMINARY RESULTS OF A SINGLE-CENTER PROSPECTIVE COHORT STUDY. HemaSphere. 7(S3). e4994547–e4994547.
13.
Terpos, Evangelos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, et al.. (2023). Safety and clinical activity of belantamab mafodotin plus lenalidomide and dexamethasone in transplant ineligible patients with newly diagnosed multiple myeloma: The phase 1/2, prospective, open-label, BelaRd study.. Journal of Clinical Oncology. 41(16_suppl). 8050–8050.
14.
Terpos, Evangelos, et al.. (2021). Clinical Application of a New SARS-CoV-2 Antigen Detection Kit (Colloidal Gold) in the Detection of COVID-19. Diagnostics. 11(6). 995–995.
15.
Terpos, Evangelos, Monika Engelhardt, Gordon Cook, et al.. (2020). Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN). Leukemia. 34(8). 2000–2011.
16.
Terpos, Evangelos, Karthik Ramasamy, Jiří Minařík, et al.. (2020). Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma. Annals of Hematology. 99(5). 1049–1061.
17.
Gavriatopoulou, Maria, Eleni Korompoki, Despina Fotiou, et al.. (2020). Organ-specific manifestations of COVID-19 infection. Clinical and Experimental Medicine. 20(4). 493–506.
18.
Eleutherakis‐Papaiakovou, Evangelos, Efstathios Kastritis, Maria Gavriatopoulou, et al.. (2018). Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström Macroglobulinemia. Clinical Lymphoma Myeloma & Leukemia. 18(6). 431–437.
19.
Tsilimigras, Diamantis I., Dimitrios Moris, Ioannis Ntanasis‐Stathopoulos, Davide Patrini, & Nikolaos Panagiotopoulos. (2018). Endobronchial Carcinoid Tumor Totally Occluding the Left Main Bronchus Without Producing Symptoms of Bronchial Obstruction. In Vivo. 31(5). 1023–1025.
20.
Schizas, Dimitriοs, Ioannis Ntanasis‐Stathopoulos, Diamantis I. Tsilimigras, et al.. (2017). The Role of Endoscopic Ultrasound in the Diagnosis and Management of Primary Gastric Lymphoma. Gastroenterology Research and Practice. 2017. 1–6.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Maria Gavriatopoulou Breakdown of academic impact, for papers by Riccardo Haupt Breakdown of academic impact, for papers by Michael von Bergwelt‐Baildon Breakdown of academic impact, for papers by Jeffrey I. Zwicker Breakdown of academic impact, for papers by Roberto Caporali Breakdown of academic impact, for papers by Eun Bong Lee Breakdown of academic impact, for papers by Wen Zhang Breakdown of academic impact, for papers by Sameer Bakhshi Breakdown of academic impact, for papers by Lai‐Shan Tam Breakdown of academic impact, for papers by Efstathios Kastritis